Oppenheimer & Co’s Barings Corporate Investors MCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,918
| Closed | -$258K | – | 1400 |
|
|
2022
Q3 | $258K | Sell |
19,918
-12,417
| -38% | -$172K | 0.01% | 1114 |
|
|
2022
Q2 | $434K | Sell |
32,335
-50,557
| -61% | -$720K | 0.01% | 970 |
|
|
2022
Q1 | $1.26M | Sell |
82,892
-8,575
| -9% | -$133K | 0.02% | 653 |
|
|
2021
Q4 | $1.46M | Sell |
91,467
-2,275
| -2% | -$36.3K | 0.03% | 626 |
|
|
2021
Q3 | $1.46M | Sell |
93,742
-350
| -0.4% | -$5.38K | 0.03% | 606 |
|
|
2021
Q2 | $1.43M | Sell |
94,092
-450
| -0.5% | -$6.67K | 0.03% | 613 |
|
|
2021
Q1 | $1.32M | Sell |
94,542
-690
| -0.7% | -$9.33K | 0.03% | 607 |
|
|
2020
Q4 | $1.25M | Sell |
95,232
-5,050
| -5% | -$64.4K | 0.03% | 571 |
|
|
2020
Q3 | $1.25M | Buy |
100,282
+4,625
| +5% | +$61.1K | 0.03% | 509 |
|
|
2020
Q2 | $1.28M | Buy |
95,657
+2,200
| +2% | +$29.2K | 0.03% | 486 |
|
|
2020
Q1 | $1.09M | Sell |
93,457
-3,100
| -3% | -$48K | 0.03% | 487 |
|
|
2019
Q4 | $1.63M | Sell |
96,557
-475
| -0.5% | -$7.96K | 0.04% | 469 |
|
|
2019
Q3 | $1.64M | Buy |
97,032
+300
| +0.3% | +$4.88K | 0.04% | 455 |
|
|
2019
Q2 | $1.51M | Sell |
96,732
-1,500
| -2% | -$23.6K | 0.04% | 466 |
|
|
2019
Q1 | $1.52M | Sell |
98,232
-600
| -0.6% | -$9.33K | 0.04% | 464 |
|
|
2018
Q4 | $1.45M | Sell |
98,832
-1,022
| -1% | -$15.4K | 0.05% | 416 |
|
|
2018
Q3 | $1.53M | Buy |
99,854
+300
| +0.3% | +$4.6K | 0.04% | 469 |
|
|
2018
Q2 | $1.5M | Sell |
99,554
-775
| -0.8% | -$11.8K | 0.04% | 459 |
|
|
2018
Q1 | $1.52M | Sell |
100,329
-1,596
| -2% | -$24.1K | 0.04% | 467 |
|
|
2017
Q4 | $1.56M | Buy |
101,925
+417
| +0.4% | +$6.56K | 0.04% | 474 |
|
|
2017
Q3 | $1.6M | Sell |
101,508
-200
| -0.2% | -$3.13K | 0.04% | 444 |
|
|
2017
Q2 | $1.53M | Buy |
101,708
+2,983
| +3% | +$45.5K | 0.04% | 460 |
|
|
2017
Q1 | $1.51M | Sell |
98,725
-2,433
| -2% | -$36.9K | 0.04% | 457 |
|
|
2016
Q4 | $1.57M | Buy |
101,158
+8,634
| +9% | +$142K | 0.05% | 438 |
|
|
2016
Q3 | $1.59M | Sell |
92,524
-3,724
| -4% | -$68K | 0.05% | 445 |
|
|
2016
Q2 | $1.73M | Sell |
96,248
-2,500
| -3% | -$43.5K | 0.05% | 412 |
|
|
2016
Q1 | $1.68M | Sell |
98,748
-6,225
| -6% | -$105K | 0.05% | 396 |
|
|
2015
Q4 | $1.81M | Sell |
104,973
-1,051
| -1% | -$17.9K | 0.05% | 378 |
|
|
2015
Q3 | $1.73M | Sell |
106,024
-301
| -0.3% | -$4.86K | 0.05% | 409 |
|
|
2015
Q2 | $1.71M | Sell |
106,325
-250
| -0.2% | -$3.97K | 0.05% | 454 |
|
|
2015
Q1 | $1.66M | Sell |
106,575
-3,408
| -3% | -$54.1K | 0.05% | 472 |
|
|
2014
Q4 | $1.75M | Buy |
109,983
+1,150
| +1% | +$18K | 0.05% | 431 |
|
|
2014
Q3 | $1.67M | Buy |
108,833
+1,300
| +1% | +$19.9K | 0.05% | 434 |
|
|
2014
Q2 | $1.64M | Sell |
107,533
-150
| -0.1% | -$2.29K | 0.05% | 434 |
|
|
2014
Q1 | $1.63M | Sell |
107,683
-200
| -0.2% | -$3.1K | 0.05% | 436 |
|
|
2013
Q4 | $1.61M | Buy |
107,883
+3,975
| +4% | +$59K | 0.05% | 406 |
|
|
2013
Q3 | $1.59M | Sell |
103,908
-726
| -0.7% | -$11.5K | 0.06% | 386 |
|
|
2013
Q2 | $1.66M | Buy |
+104,634
| New | +$1.73M | 0.06% | 350 |
|
Other funds holding MCI
RCM
CFMC
BIA
B
BFEC
SIG
TCMG
Oppenheimer & Co's MCI Position: Q4 2022 in Review
Oppenheimer & Co sold out of Barings Corporate Investors (MCI) in Q4 2022, closing a stake of 19,918 shares — an estimated $258K sold.
Oppenheimer & Co first reported a position in MCI in Q2 2013 and held it in 38 quarters. The position peaked at $1.81M in Q4 2015. 57 funds tracked by Wall St. Rank hold MCI as of Q4 2022.
- Oppenheimer & Co reported no remaining Barings Corporate Investors position as of Q4 2022 after selling out during the quarter.
- Oppenheimer & Co sold 19,918 Barings Corporate Investors shares in Q4 2022, an estimated $258K.
- Oppenheimer & Co first reported a position in Barings Corporate Investors in Q2 2013 and held it in 38 quarters.
- Oppenheimer & Co's Barings Corporate Investors position peaked at $1.81M in Q4 2015.
- 57 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q4 2022.
Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.